Prescription / GLP-1semaglutide online

Semaglutide Online: Getting Wegovy or Ozempic Legally, With Prices

How to get semaglutide online legally: Novo self-pay, a telehealth prescription filled by a licensed pharmacy, or compounding, with Wegovy and Ozempic prices.

Written bySebastian Hunter, Founder and EditorI'm a 42-year-old senior advisor and distance runner who came to peptides as a sceptic. I'm not a doctor: I read the research, run my own experiment and keep honest notes. Read full bio

Published October 3, 2026

The short version

You can get semaglutide online legally, but only with a prescription. As of 3 October 2026, Novo Nordisk's self-pay price for the Wegovy pill is $149 to $299 a month. The Wegovy pen is $349 after two $199 introductory fills. Ozempic, approved for type 2 diabetes, is $349 to $499 for the pen. Compounded semaglutide is not FDA-approved and is now tightly limited. A vial sold online as a research peptide is not a legal way to get it.

Every legal route needs a prescription from a prescriber licensed in the state where you are.
Wegovy self-pay: pill $149 (1.5 mg), $199 (4 mg), $299 (9 or 25 mg); pen $349 after two $199 intro fills; HD $399.
With commercial insurance that covers it, Novo can cut Wegovy or Ozempic to $25 a month; Medicare Part D may cover Wegovy for $50.
FDA says semaglutide sodium and acetate, used by some compounders, are different active ingredients from the approved drug.

You can get semaglutide online legally, but only with a prescription. As of 3 October 2026, Novo Nordisk’s self-pay price for the Wegovy pill is $149 to $299 a month. The Wegovy pen is $349 after two $199 introductory fills. The Ozempic pen, approved for type 2 diabetes, is $349 to $499.

A vial sold online as a “research” peptide, with no prescription, is not a legal way to get it and is not the same product.

Three legal routes to semaglutide online

1. Novo Nordisk self-pay. Novo publishes self-pay prices for Wegovy and Ozempic, through its NovoCare Pharmacy or as a savings offer used at other pharmacies, and Costco lists the same prices. You still need a prescription, from your own doctor or a telehealth prescriber.

2. A prescriber plus a licensed pharmacy. A doctor, nurse practitioner or physician associate, in person or by telehealth, prescribes Wegovy or Ozempic, and a licensed retail or mail-order pharmacy fills it. This is the route that can use insurance or Novo’s savings offer. The prescriber generally has to be licensed in the state where you are at the time of the consult. See peptide telehealth for what a real consult involves.

3. Compounded semaglutide (narrow). A state-licensed 503A pharmacy can compound semaglutide for an individual patient’s prescription. The product is not FDA-approved, and the rules have tightened:

FDA’s shortage-era enforcement discretion for semaglutide had ended for both 503A pharmacies and 503B outsourcing facilities by 22 May 2025.
Semaglutide is not on FDA’s shortage list or its 503B bulks list, so outsourcing facilities may not compound it from bulk ingredients.
FDA treats a compounded product with the same ingredient, a similar strength and the same route as “essentially a copy” of an approved drug. The exception is when a prescriber documents a significant difference for that patient.
A product with added vitamin B12 may still count as a copy when both amounts are within 10% of the approved products’ strengths.
FDA says it does not intend to act against a pharmacy that fills four or fewer prescriptions of such a copy in a calendar month.
On 6 February 2026, FDA said it intends to restrict the GLP-1 ingredients used in mass-marketed compounded copies. On 3 March 2026 it announced warning letters to 30 telehealth companies over claims that compounded GLP-1s are the same as approved drugs.

Semaglutide prices online (3 October 2026)

Novo Nordisk self-pay prices:

Product and dose	Self-pay price a month
Wegovy pill, 1.5 mg (30 tablets)	$149
Wegovy pill, 4 mg	$199
Wegovy pill, 9 mg or 25 mg	$299
Wegovy pen, 0.25 or 0.5 mg (4 pens)	$199 for the first two fills (new patients, through 31 December 2026), then $349
Wegovy pen, 1, 1.7 or 2.4 mg	$349
Wegovy HD pen, 7.2 mg	$399
Ozempic pen, 0.25, 0.5 or 1 mg (1 pen)	$349 ($199 for the first two fills of 0.25 or 0.5 mg for new self-pay patients)
Ozempic pen, 2 mg	$499
Ozempic pill, 1.5, 4 or 9 mg	$149, $199 or $299

Costco’s member prices on the same day were the same, except that Costco showed only the $199 price for the starting pens. Novo says Rybelsus is being replaced by the Ozempic pill.

Other ways to pay:

Programme	Price	Conditions
Novo savings offer	$25 a month	Commercial insurance that covers Wegovy or Ozempic; savings capped at $100 a month; government plans excluded
Medicare GLP-1 Bridge	$50 a month	Medicare Part D, Wegovy pen or pill for weight management, 1 July 2026 to 31 December 2027; eligibility rules apply
Medicare Part D, Ozempic	Varies by plan	Novo says most Part D plans cover Ozempic; Part D members cannot use the $25 offer but can use self-pay

The list price, which most insured patients do not pay, is $1,349.02 per package for Wegovy and $1,027.51 per pen for Ozempic. Novo will cut the list price of Wegovy 2.4 mg, the 25 mg Wegovy pill and Ozempic to $675 on 1 January 2027. It says self-pay prices are not affected. For tirzepatide and the full comparison, see cheapest tirzepatide and semaglutide.

FDA’s red flags for online sellers

FDA publishes warning signs for online and telehealth sellers of GLP-1 drugs. Be wary of a seller that:

Claims a compounded drug is the same as an FDA-approved one.
Offers deep discounts or prices that seem too good to be true.
Sends medicine that looks different from before, or arrives damaged.
Does not require screening and a prescription by a licensed doctor.
Has no licensed doctor available to answer questions afterwards.
Has spelling errors on the label or an incorrect pharmacy address.
Uses a pharmacy name that looks fraudulent.

FDA also reports counterfeit Ozempic marketed in the US. Its advice is to get a prescription from your doctor and fill it at a state-licensed pharmacy.

What FDA has found in compounded semaglutide

FDA has raised four specific concerns about compounded semaglutide:

Different salt forms. FDA says semaglutide sodium and semaglutide acetate, used in some compounded products, are different active ingredients from the one in the approved drugs.
Dosing errors. FDA has received reports of adverse events, some needing hospital care, that may be linked to dosing errors with compounded injectable semaglutide.
Warm deliveries. It has had complaints of compounded GLP-1s arriving warm or with inadequate ice packs.
Adverse events. As of 31 May 2026, FDA had received 990 adverse event reports tied to compounded semaglutide. Pharmacies that are not outsourcing facilities do not have to report them, so the true count is likely higher.

A legitimate clinic should name the licensed pharmacy filling the prescription and state the exact active ingredient and salt form in writing.

Why a “research” semaglutide vial is not the same product

Websites selling “research” semaglutide are not a fourth route. FDA has warned companies that illegally sold unapproved drugs containing semaglutide, tirzepatide, retatrutide and other GLP-1s. The products were falsely labelled “for research purposes” or “not for human consumption”. FDA says they were sold directly to consumers for human use, with dosing instructions.

Such a vial differs from Wegovy or Ozempic in every way that matters for safety:

No drug approval. No regulator has reviewed how it is made, what is in it or how much.
No prescriber. No one screens for the conditions that rule semaglutide out, such as a family history of medullary thyroid cancer.
No pharmacy. No licensed pharmacist checks the product, its storage or its label.

For what a certificate of analysis can and cannot show, see how to read a peptide COA. For the legal side, see research peptides and the law.

Common questions

Can I buy Ozempic online legally?

Yes, with a prescription. A licensed prescriber, including a telehealth one, can prescribe Ozempic and send it to a licensed pharmacy that delivers. Novo Nordisk also offers self-pay prices. Ozempic is approved for type 2 diabetes, so prescribing it for weight loss is off-label. Wegovy is the semaglutide brand approved for weight management.

Can I buy semaglutide online?

Only with a prescription. The legal options are Wegovy or Ozempic prescribed by a licensed clinician and filled by a licensed pharmacy, including Novo Nordisk's self-pay offers. In narrow cases, a compounded product from a named state-licensed pharmacy is also legal. Semaglutide sold without a prescription, or labelled for research, is not a legal route for human use.

Is there a way to get Ozempic over the counter?

No. Ozempic and Wegovy are prescription-only in the US, and I found no over-the-counter semaglutide. FDA's advice is to get a prescription from your doctor and fill it at a state-licensed pharmacy.

How do I get semaglutide for $25?

Only with commercial insurance that covers it. Novo Nordisk's savings offer brings Wegovy or Ozempic to as little as $25 a month, with savings capped at $100 a month. It excludes government plans such as Medicare and Medicaid. Eligible Medicare Part D members can instead get Wegovy for $50 a month through the Medicare GLP-1 Bridge.

How much do semaglutide pills cost per month?

As of 3 October 2026, Novo Nordisk's self-pay price for the Wegovy pill is $149 a month for 1.5 mg and $199 for 4 mg. The 9 mg and 25 mg doses are $299. The Ozempic pill, approved for type 2 diabetes, is $149, $199 and $299 for 1.5 mg, 4 mg and 9 mg. A month is one bottle of 30 tablets.

What's the cheapest I can buy Ozempic?

Without insurance, as of 3 October 2026, the Ozempic pill starts at $149 a month for 1.5 mg. New self-pay patients pay $199 a month for the first two fills of the 0.25 mg or 0.5 mg pen, through 31 December 2026. After that the pen is $349 a month for 0.25 mg to 1 mg, and $499 for 2 mg. With commercial insurance that covers it, Novo's offer can bring it to $25.

What is equivalent to Ozempic but cheaper?

The same molecule costs less in some forms. The Ozempic pill is $149 to $299 a month against $349 to $499 for the pen, and the Wegovy pen is $349. Compounded semaglutide is not an equivalent. It is not FDA-approved, and FDA says sellers may not claim compounded GLP-1 drugs are the same as, or generic versions of, approved ones.

Can I get semaglutide from a pharmacy?

Yes, with a prescription. Retail and mail-order pharmacies fill Wegovy and Ozempic. Costco's member prices on 3 October 2026 were in line with Novo's self-pay prices. The pills were $149 to $299 and the starting pens $199. Higher Wegovy or Ozempic doses were $349, Wegovy HD $399 and Ozempic 2 mg $499.

Is compounded semaglutide legal?

Only in narrow cases. FDA's shortage-era allowance for compounding semaglutide ended by May 2025. A 503A pharmacy may still compound for an individual patient. FDA treats a similar-strength injectable, including one with added vitamin B12, as a copy of approved semaglutide. The exception is when a prescriber documents a significant difference for that patient. FDA says it does not intend to act against a pharmacy filling four or fewer such copies a month.

Is Wegovy available online?

Yes, with a prescription. A licensed prescriber, including a telehealth one, can prescribe Wegovy and send it to a licensed pharmacy that delivers. Novo Nordisk's self-pay prices on 3 October 2026 were $149 to $299 a month for the pill and $349 for the pen after two $199 introductory fills. Wegovy HD was $399.

References (16 sources)

Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.

1.What to pay for Wegovy: self-pay prices for the Wegovy pill, pen and HD pen, the intro offer, the commercial savings offer and the Medicare GLP-1 Bridge (checked 3 October 2026).- Novo Nordisk Inc.other
2.NovoCare Wegovy page: list price of $1,349.02 per package for the Wegovy pill, pen and HD pen (checked 3 October 2026).- Novo Nordisk Inc.other
3.Save on Ozempic: self-pay prices for the Ozempic pen and pill, the intro offer, the commercial savings offer and the Medicare statement (checked 3 October 2026).- Novo Nordisk Inc.other
4.NovoCare Ozempic list price page: $1,027.51 per pen or package (checked 3 October 2026).- Novo Nordisk Inc.other
5.NovoCare Rybelsus page: Rybelsus is being replaced by the Ozempic pill (checked 3 October 2026).- Novo Nordisk Inc.other
6.Novo Nordisk news release, 24 February 2026: list price of Wegovy, Ozempic and Rybelsus to fall to $675 from 1 January 2027; self-pay prices not affected.- Novo Nordisknews
7.Costco Pharmacy member prices for Wegovy pens and tablets by strength (checked 3 October 2026).- Costco Pharmacyother
8.Costco Pharmacy member prices for Ozempic tablets by strength (checked 3 October 2026).- Costco Pharmacyother
9.Costco Pharmacy member prices for Ozempic pens: $199 (0.25 or 0.5 mg), $349 (1 mg), $499 (2 mg) (checked 3 October 2026).- Costco Pharmacyother
10.Medicare.gov - weight loss drugs: the Medicare GLP-1 Bridge covers Wegovy (injection or tablet) from 1 July 2026, with a $50 monthly copay.- Centers for Medicare & Medicaid Servicesregulatory
11.OZEMPIC (semaglutide) injection prescribing information: type 2 diabetes indications.- DailyMed, National Library of Medicinelabel
12.WEGOVY (semaglutide) injection and tablets prescribing information: weight-management indications, dosage forms, adverse reactions and boxed warning.- DailyMed, National Library of Medicinelabel
13.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (updated 1 October 2026): telehealth red flags, salt forms, dosing errors, warm deliveries, counterfeits, research-labelled products and adverse event counts.- US Food and Drug Administrationregulatory
14.FDA - FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (updated 1 April 2026): end of enforcement discretion, essentially-a-copy test, the B12 example, four prescriptions a month, 503B limits.- US Food and Drug Administrationregulatory
15.FDA news release, 6 February 2026: FDA intends to restrict GLP-1 ingredients used in mass-marketed non-approved compounded drugs, and limits marketing claims.- US Food and Drug Administrationregulatory
16.FDA news release, 3 March 2026: warning letters to 30 telehealth companies over claims of sameness and obscured sourcing for compounded GLP-1 drugs.- US Food and Drug Administrationregulatory